Eszter Pakai, Krisztian Klonfar, Anna Walter, Nelli Farkas, Anna Sara Bognar, Jimin Lee, Peter Hegyi, Andras Garami
{"title":"Fever on hospital admission is associated with increased disease severity and mortality in acute pancreatitis: a systematic review and meta-analysis.","authors":"Eszter Pakai, Krisztian Klonfar, Anna Walter, Nelli Farkas, Anna Sara Bognar, Jimin Lee, Peter Hegyi, Andras Garami","doi":"10.1186/s13643-026-03265-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Acute pancreatitis (AP) is often accompanied by changes in body temperature (T<sub>b</sub>), but whether and how T<sub>b</sub> at hospital admission is associated with the outcome of the disease remained unclear. Previous studies showed contradictory results regarding its prognostic value, and no meta-analysis was performed.</p><p><strong>Methods: </strong>In this systematic review and meta-analysis, we searched the PubMed, Embase, and CENTRAL databases (from inception to April 25, 2024) for studies in adult AP patients with reported admission T<sub>b</sub> and mortality rate or a disease severity marker. With a random-effects model, we calculated pooled proportion (for mortality) or pooled mean (for secondary outcomes) with 95% CI and compared them between febrile and afebrile subgroups. With meta-regression, we assessed the correlation between admission T<sub>b</sub> and mortality or length of hospital stay (LOS).</p><p><strong>Results: </strong>We found 26 eligible studies including data from 40,630 AP patients. The pooled mortality rate was higher (p < 0.001) in febrile patients (0.15, 95% CI 0.11-0.20; I<sup>2</sup> = 40%) than in afebrile patients (0.05, 95% CI 0.03-0.09; I<sup>2</sup> = 98%). LOS was longer (p = 0.025) in the febrile subgroup (39.1 days, 95% CI 16.8-61.4; I<sup>2</sup> = 91%) than in the afebrile subgroup (17.5 days, 95% CI 7.6-27.5; I<sup>2</sup> = 96%). With meta-regression, admission T<sub>b</sub> significantly and positively correlated with mortality (0.09, 95% CI 0.07-0.12) and LOS (16.5, 95% CI 5.6-27.5). The APACHE II score was significantly (p = 0.030) higher, while the SOFA score tended to be higher (p = 0.168) in the febrile than in the afebrile subgroup. Blood levels of amylase and C-reactive protein did not differ meaningfully between the groups.</p><p><strong>Conclusions: </strong>Fever on admission is associated with higher mortality, increased disease severity, and longer hospitalization in AP. High-quality studies with standardized T<sub>b</sub> measurements are needed to determine the prognostic performance of admission T<sub>b</sub> in AP.</p><p><strong>Systematic review registration: </strong>This study was registered with PROSPERO on 16 January 2020 (registration number: CRD42020139154).</p>","PeriodicalId":22162,"journal":{"name":"Systematic Reviews","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2026-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13670636/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Systematic Reviews","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13643-026-03265-z","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Acute pancreatitis (AP) is often accompanied by changes in body temperature (Tb), but whether and how Tb at hospital admission is associated with the outcome of the disease remained unclear. Previous studies showed contradictory results regarding its prognostic value, and no meta-analysis was performed.
Methods: In this systematic review and meta-analysis, we searched the PubMed, Embase, and CENTRAL databases (from inception to April 25, 2024) for studies in adult AP patients with reported admission Tb and mortality rate or a disease severity marker. With a random-effects model, we calculated pooled proportion (for mortality) or pooled mean (for secondary outcomes) with 95% CI and compared them between febrile and afebrile subgroups. With meta-regression, we assessed the correlation between admission Tb and mortality or length of hospital stay (LOS).
Results: We found 26 eligible studies including data from 40,630 AP patients. The pooled mortality rate was higher (p < 0.001) in febrile patients (0.15, 95% CI 0.11-0.20; I2 = 40%) than in afebrile patients (0.05, 95% CI 0.03-0.09; I2 = 98%). LOS was longer (p = 0.025) in the febrile subgroup (39.1 days, 95% CI 16.8-61.4; I2 = 91%) than in the afebrile subgroup (17.5 days, 95% CI 7.6-27.5; I2 = 96%). With meta-regression, admission Tb significantly and positively correlated with mortality (0.09, 95% CI 0.07-0.12) and LOS (16.5, 95% CI 5.6-27.5). The APACHE II score was significantly (p = 0.030) higher, while the SOFA score tended to be higher (p = 0.168) in the febrile than in the afebrile subgroup. Blood levels of amylase and C-reactive protein did not differ meaningfully between the groups.
Conclusions: Fever on admission is associated with higher mortality, increased disease severity, and longer hospitalization in AP. High-quality studies with standardized Tb measurements are needed to determine the prognostic performance of admission Tb in AP.
Systematic review registration: This study was registered with PROSPERO on 16 January 2020 (registration number: CRD42020139154).
期刊介绍:
Systematic Reviews encompasses all aspects of the design, conduct and reporting of systematic reviews. The journal publishes high quality systematic review products including systematic review protocols, systematic reviews related to a very broad definition of health, rapid reviews, updates of already completed systematic reviews, and methods research related to the science of systematic reviews, such as decision modelling. At this time Systematic Reviews does not accept reviews of in vitro studies. The journal also aims to ensure that the results of all well-conducted systematic reviews are published, regardless of their outcome.